Cargando…
A Novel Anti-PD-L1 Antibody Exhibits Antitumor Effects on Multiple Myeloma in Murine Models via Antibody-Dependent Cellular Cytotoxicity
Multiple myeloma is a malignant cancer of plasma cells. Despite recent progress with immunomodulatory drugs and proteasome inhibitors, it remains an incurable disease that requires other strategies to overcome its recurrence and non-response. Based on the high expression levels of programmed death-l...
Autores principales: | Ahn, Jae-Hee, Lee, Byung-Hyun, Kim, Seong-Eun, Kwon, Bo-Eun, Jeong, Hyunjin, Choi, Jong Rip, Kim, Min Jung, Park, Yong, Kim, Byung Soo, Kim, Dae Hee, Ko, Hyun-Jeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921862/ https://www.ncbi.nlm.nih.gov/pubmed/33139584 http://dx.doi.org/10.4062/biomolther.2020.131 |
Ejemplares similares
-
Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines
por: Park, Ji-Eun, et al.
Publicado: (2020) -
Development of a CHO cell line for stable production of recombinant antibodies against human MMP9
por: Ryu, Jina, et al.
Publicado: (2022) -
Bispecific Antibody-Bound T Cells as a Novel Anticancer Immunotherapy
por: Cho, Jaewon, et al.
Publicado: (2022) -
A New Trial to Measure ABO Antibodies Using Complement-Dependent Cytotoxicity
por: Youk, Hee-Jeong, et al.
Publicado: (2022) -
BLI-Based Functional Assay in Phage Display Benefits the Development of a PD-L1-Targeting Therapeutic Antibody
por: Choi, Jong Rip, et al.
Publicado: (2020)